Oct. 6 at 5:42 PM
The B2i Digital team is pleased to introduce eXoZymes (Nasdaq:
$EXOZ) Inc. as a new B2i Digital Featured Company. A full company profile will be available soon at https://b2idigital.com/featured-companies
eXoZymes is a Los Angeles, California-based biotechnology company pioneering cell-free biomanufacturing through its proprietary exozyme platform. The company has developed AI-engineered enzymes that operate outside living cells to transform sustainable feedstock into nutraceuticals, medicines, and essential chemicals, offering a scalable and commercially viable alternative to traditional petrochemical production methods, natural extraction, or synthetic biology.
Founded on technology validated through multiple peer-reviewed publications in Nature Communications and Nature Chemical Biology, eXoZymes focuses on high-value, low-volume products including active pharmaceutical ingredients, nutraceuticals, and sustainable aviation fuel. The company recently demonstrated its platform’s capabilities by achieving gram-scale production of NCT (a nutraceutical compound) with over 99% purity in just five months, showcasing the speed and efficiency of its cell-free approach.
With
$1.4 million in grant income through Q2 2025 from sources including NIH, NSF, and BioMADE, eXoZymes is advancing multiple projects including its lead NCT program targeting the non-alcoholic fatty liver disease (NAFLD) treatment market, estimated at
$21 billion. The company’s BioClick platform, supported by NIH, accelerates enzyme engineering through high-throughput screening capabilities and novel ways of implementing AI.
eXoZymes is led by an experienced management team including Michael Heltzen, CEO; Damien Perriman, CCO; Dr. Tyler Korman, VP of Research and Co-founder; Dr. Paul Opgenorth, VP of Development and Co-founder; Fouad Nawaz, VP of Finance; Dr. Zachary Karl, Ph.D., VP of Business Development; and Lasse H. Görlitz, VP of Communications & IR.
To learn more about eXoZymes Inc., visit https://exozymes.com. For investor inquiries, visit https://exozymes.com/investor.
Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com